Maia Biotechnology IncNYSE American:MAIA
- LAST PRICE1.8000
- TODAY'S CHANGE (%)0.1900 (11.8012%)
- Bid / Lots1.6500/ 2
- Ask / Lots2.0500/ 10
- Open / Previous Close1.6400 / 1.6100
- Day Range
- 52 Week Range
- Volume125,685
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MAIA |
|---|---|---|
| 09:32 ET | 176 | 1.64 |
| 09:34 ET | 700 | 1.62 |
| 09:36 ET | 800 | 1.62 |
| 09:38 ET | 1300 | 1.62 |
| 09:41 ET | 930 | 1.62 |
| 09:43 ET | 100 | 1.63 |
| 09:45 ET | 1200 | 1.62 |
| 09:50 ET | 146 | 1.64 |
| 09:52 ET | 1400 | 1.64 |
| 09:56 ET | 1269 | 1.66 |
| 10:01 ET | 1590 | 1.67 |
| 10:03 ET | 2100 | 1.66 |
| 10:06 ET | 200 | 1.69 |
| 10:12 ET | 5100 | 1.74 |
| 10:14 ET | 400 | 1.7399 |
| 10:15 ET | 2770 | 1.7469 |
| 10:17 ET | 1400 | 1.7 |
| 10:24 ET | 541 | 1.73 |
| 10:30 ET | 6500 | 1.7 |
| 10:32 ET | 100 | 1.725 |
| 10:37 ET | 100 | 1.725 |
| 10:42 ET | 5400 | 1.74 |
| 10:44 ET | 426 | 1.71 |
| 10:53 ET | 6600 | 1.72 |
| 10:55 ET | 5300 | 1.72 |
| 10:57 ET | 1700 | 1.72 |
| 11:22 ET | 1318 | 1.726 |
| 11:24 ET | 2353 | 1.7 |
| 11:26 ET | 228 | 1.7001 |
| 11:27 ET | 100 | 1.7094 |
| 11:38 ET | 100 | 1.71 |
| 11:47 ET | 1000 | 1.73 |
| 11:54 ET | 100 | 1.73 |
| 12:12 ET | 600 | 1.745 |
| 12:14 ET | 8935 | 1.72 |
| 12:21 ET | 2266 | 1.73 |
| 12:32 ET | 170 | 1.75 |
| 12:34 ET | 2734 | 1.75 |
| 12:43 ET | 6200 | 1.74 |
| 12:54 ET | 1585 | 1.74 |
| 12:56 ET | 10164 | 1.76 |
| 01:01 ET | 300 | 1.74 |
| 01:46 ET | 300 | 1.7499 |
| 02:02 ET | 3700 | 1.75 |
| 02:06 ET | 100 | 1.75 |
| 02:38 ET | 1400 | 1.73 |
| 03:03 ET | 599 | 1.73 |
| 03:05 ET | 300 | 1.77 |
| 03:07 ET | 1800 | 1.74 |
| 03:25 ET | 1000 | 1.76 |
| 03:27 ET | 100 | 1.775 |
| 03:34 ET | 100 | 1.7831 |
| 03:45 ET | 7199 | 1.7815 |
| 03:48 ET | 8763 | 1.79 |
| 03:50 ET | 4471 | 1.78 |
| 03:52 ET | 2800 | 1.81 |
| 03:57 ET | 1500 | 1.82 |
| 03:59 ET | 944 | 1.8 |
Today
MAIA Biotechnology Announces Share Repurchase Program, from 15 hours ago by Dow Jones
15 hours ago by Dow Jones*DJ MAIA Biotechnology Announces Share Repurchase Program >MAIA, from 15 hours ago by Dow Jones
15 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Maia Biotechnology Inc | 22.0M | -1.1x | --- |
Genprex Inc | 22.2M | -0.6x | --- |
Indaptus Therapeutics Inc | 22.3M | -1.6x | --- |
Alzamend Neuro Inc | 22.6M | -1.5x | --- |
AIM ImmunoTech Inc | 22.4M | -1.1x | --- |
Sensei Biotherapeutics Inc | 21.0M | -0.5x | --- |
Company Information
MAIA Biotechnology, Inc. is a biopharmaceutical company. The Company is focused on developing oncology drug candidates to improve and extend the lives of people with cancer. The Company’s pipeline includes several targeted immuno-oncology therapies for difficult-to-treat cancers. The Company's THIO (6-thio-dG, 6-thio-2’-deoxyguanosine) is a potentially first-in-class small molecule that is a telomere-targeting agent in clinical development. THIO is followed by Libtayo for the treatment of advanced non-small-cell lung cancer. The Company is advancing THIO in Phase II clinical study in Non-Small Cell Lung Cancer. The Company's second-generation program is engaged in discovering new compounds with potentially improved specificity towards cancer cells relative to normal cells and with potentially increased anticancer activity. The second-generation pipeline of potential telomere-targeting agents includes five compounds that have undergone in vitro inhibitory testing in five cancer models.
Contact Information
- Headquarters
- 444 West Lake Street Suite 1700, Suite 1700CHICAGO, IL, United States 60606
- Phone
- 312-416-8592
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer, Co-Founder
- Vlad Vitoc
- Chief Financial Officer
- Joseph Mcguire
- Chief Scientific Officer
- Sergei Gryaznov
- Chief Medical Officer
- Mihail Obrocea
- Independent Director
- Steven Chaouki
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $22.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 13.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.59 |
Book Value | $0.78 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
